Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
MBX Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
MBX
Nasdaq
2836
mbxbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for MBX Biosciences, Inc.
MBX Biosciences to Participate in Upcoming February Investor Conferences
- Jan 23rd, 2025 1:00 pm
MBX Biosciences' Investigational Drug For Weight Loss Surgery-Related Low Blood Sugar Shows Encouraging Action
- Jan 7th, 2025 4:47 pm
MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia
- Jan 7th, 2025 12:00 pm
MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference
- Dec 18th, 2024 1:00 pm
MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism
- Dec 2nd, 2024 1:00 pm
MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
- Nov 18th, 2024 1:00 pm
MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
- Nov 7th, 2024 1:00 pm
MBX Biosciences to Participate in Upcoming November Investor Conferences
- Oct 28th, 2024 12:00 pm
Opening Day: Another trio of biotech IPOs make Friday debut
- Oct 14th, 2024 10:45 am
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting
- Sep 30th, 2024 12:00 pm
OrbiMed Advisors LLC Acquires New Stake in MBX Biosciences Inc
- Sep 18th, 2024 7:19 am
MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Sep 16th, 2024 8:05 pm
MBX Biosciences Announces Pricing of Initial Public Offering
- Sep 12th, 2024 11:11 pm
Will MBX Biosciences (NASDAQ:MBX) Spend Its Cash Wisely?
- Sep 12th, 2024 5:50 pm
Scroll